HERCULES, CA--(Marketwire - October 07, 2008) - Bio-Rad Laboratories, Inc. (AMEX: BIO) and (AMEX: BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced its intent to transfer trading of its stock to the New York Stock Exchange ("NYSE") from the American Stock Exchange ("AMEX"). Bio-Rad will continue to trade its stock under two ticker symbols: BIO (for its Class A Common Stock) and BIOb (for its Class B Common Stock). The Company anticipates that trading on the NYSE Big Board will begin on or about October 24, 2008.
